Schrohenloher R E, Koopman W J, Moldoveanu Z, Solomon A
J Immunol. 1985 Mar;134(3):1469-74.
Differences in rheumatoid factor (RF) activity among the molecular species of IgA were investigated with the use of monomeric and polymeric monoclonal IgA RF paraprotein from the serum of a patient (PS) with idiopathic hyperviscosity syndrome. After fractionation by gel chromatography in acidic buffer, RF activity as determined by latex fixation and solid-phase radioimmunoassay (RIA) specific for IgA RF was confined to the high m.w. (greater than 7S) fractions. However, after adsorption into polystyrene wells, fractions containing monomeric (7S) IgA, as well as those containing polymeric IgA, bound 125I-labeled heat-aggregated human IgG. These observations were confirmed after further purification of the IgA fractions by passage through a protein A-Sepharose CL-4B column followed by precipitation of the IgA proteins with ammonium sulfate at 50% saturation. After "cross-linkage" by a hybridoma anti-human alpha-chain antibody, the activity of the monomeric IgA preparation in the IgA RF RIA approached that of the polymeric IgA preparation. Gel filtration studies verified that this activity was not due to contamination by polymeric IgA RF. Further, classic RF specificity was confirmed for both the monomeric and polymeric IgA RF by reaction with human Fc-coated but not Fab-coated wells. A control monomeric IgA myeloma protein and normal serum IgA did not react in the RF RIA when analyzed in the presence or absence of the hybridoma anti-alpha-chain antibody. Moreover, the activity of the polymeric IgA RF preparation from patient PS in the RIA was minimally influenced by the hybridoma antibody. These results indicate that IgA RF can coexist in both polymeric and monomeric forms, demonstrate that monomeric IgA RF may escape detection by previously described RIA techniques, and suggest an approach for its detection.
利用来自一名患有特发性高粘滞综合征患者(PS)血清中的单体和聚合单克隆IgA类风湿因子(RF)副蛋白,研究了IgA分子种类之间RF活性的差异。在酸性缓冲液中通过凝胶色谱分离后,通过乳胶凝集法和针对IgA RF的固相放射免疫测定(RIA)测定的RF活性局限于高分子量(大于7S)组分。然而,吸附到聚苯乙烯孔中后,含有单体(7S)IgA的组分以及含有聚合IgA的组分都能结合125I标记的热聚集人IgG。通过蛋白A-琼脂糖CL-4B柱进一步纯化IgA组分,然后用50%饱和度的硫酸铵沉淀IgA蛋白后,这些观察结果得到了证实。用杂交瘤抗人α链抗体“交联”后,单体IgA制剂在IgA RF RIA中的活性接近聚合IgA制剂。凝胶过滤研究证实这种活性不是由于聚合IgA RF的污染。此外,通过与人Fc包被而非Fab包被的孔反应,证实了单体和聚合IgA RF都具有经典的RF特异性。在有或没有杂交瘤抗α链抗体的情况下进行分析时,对照单体IgA骨髓瘤蛋白和正常血清IgA在RF RIA中均无反应。此外,患者PS的聚合IgA RF制剂在RIA中的活性受杂交瘤抗体的影响最小。这些结果表明,IgA RF可以以聚合和单体两种形式共存,证明单体IgA RF可能会逃过先前描述的RIA技术的检测,并提出了一种检测方法。